Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rocketed 27.5% higher on Friday, Jan. 10, 2024. Investors of all stripes are ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit on Friday and indicated that ...

High street pharmacy giant Boots has warned it faces “heightened cost pressures” in 2025 following the Autumn Budget as it ...

Walgreens Boots Alliance Inc (NASDAQ: WBA) reported first-quarter sales of $39.46 billion, up 7.5% year over year (+6.9% on ...

Bank of America Securities analyst Allen Lutz reiterated a Sell rating on Walgreens Boots Alliance (WBA – Research Report) today and set a ...

BofA raised the firm’s price target on Walgreens Boots Alliance (WBA) to $8.50 from $7.50 and keeps an Underperform rating on the shares after ...

Looking forward, Walgreens Boots Alliance is maintaining its adjusted EPS (earnings per share) guidance for fiscal 2025 between $1.40 to $1.80. The company expects growth from its U.S. Healthcare and ...

Boots UK comparable pharmacy sales increased 10.9 percent and comparable retail sales increased 8.1 percent compared to the ...